Alcon AG | ALC - Cost Of Sales


Alcon AG reported $1.18B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Smith & Nephew USD 870M 17M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025
UCB EUR 1.07B 146M Dec/2025